TauRx Submits UK Marketing Authorization For HMTM As Alzheimer`s Treatment
01 Jul 2024 //
BUSINESSWIRE
TauRx to Present Two-Year Data from Ph III Trial of HMTM in Alzheimer’s Disease
05 Feb 2024 //
BUSINESSWIRE
TauRx Announces Investment of USD119M & announcement of PIII LUCIDITY Results
14 Nov 2022 //
PRNEWSWIRE
Investors add $119m to TauRx’ kitty as tau drug filing nears
14 Nov 2022 //
PHARMAPHORUM
TauRx`s late-stage clinical trial reaches new milestone
14 Apr 2022 //
PRNEWSWIRE